The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy.
Stanislav SimekZuzana MotovskaOta HlinomazPetr KalaMilan HromadkaJiri KnotIvo VarvarovskyJaroslav DusekRichard RokytaFrantisek TousekMichal SvobodaAlexandra VodzinskaJan MrozekJiri Jarkovskynull On Behalf Of The Prague-Study GroupPublished in: Journal of clinical medicine (2020)
Despite best practices STEMI treatment, diabetes is still associated with significantly worse prognoses, which highlights the importance of further improvements in the management of this high-risk population.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- type diabetes
- acute coronary syndrome
- cardiovascular disease
- glycemic control
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- primary care
- heart failure
- healthcare
- left ventricular
- combination therapy
- metabolic syndrome
- anti inflammatory
- adipose tissue
- atrial fibrillation
- insulin resistance